Stable Istotope Labelled Solitomab Biosimilar – Anti-CD3E/EpCAM mAb – Research Grade

Reference: PX-TA1282-SIL-1MG
Product nameStable Istotope Labelled Solitomab Biosimilar - Anti-CD3E/EpCAM mAb - Research Grade
SourceCAS 1005198-65-1
SpeciesMus musculus
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsMT110
ReferencePX-TA1282-SIL
Related ProductsPX-P4036
NoteFor research use only. Not suitable for clinical or therapeutic use.
Isotype(scFv-kappa-heavy)-(scFv-heavy-kappa)
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-CD3E/EpCAM[Homo sapiens] (Solitomab) Monoclonal Antibody

Solitomab has been investigated for the treatment of Lung Cancer, Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Solitomab Biosimilar – Anti-CD3E/EpCAM mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below